Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Cevidoplenib (SKI-O-703) in Active Rheumatoid Arthritis
NCT04057118Phase 2Completed
- Sponsor
- Oscotec Inc.
- Start
- Mar 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of cevidoplenib in rheumatoid arthritis (RA), sponsored by Oscotec Inc.. Started Mar 2019; status: completed.
02
Drugs
cevidoplenib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04057118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04057118.